scholarly journals Mobilizing the social infrastructure of informal settlements in infectious disease response – The case of Ebola Virus Disease in West Africa

2022 ◽  
Vol 217 ◽  
pp. 104256
Author(s):  
S. Harris Ali ◽  
Mosoka P. Fallah ◽  
Joseph Mustapha McCarthy ◽  
Roger Keil ◽  
Creighton Connolly
The Lancet ◽  
2014 ◽  
Vol 384 (9957) ◽  
pp. 1843 ◽  
Author(s):  
Shevin T Jacob ◽  
Ian Crozier ◽  
John S Schieffelin ◽  
Robert Colebunders

2015 ◽  
Vol 17 (2) ◽  
pp. 84-97 ◽  
Author(s):  
Kelvin K.W. To ◽  
Jasper F.W. Chan ◽  
Alan K.L. Tsang ◽  
Vincent C.C. Cheng ◽  
Kwok-Yung Yuen

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
T. R. W. Tipton ◽  
Y. Hall ◽  
J. A. Bore ◽  
A. White ◽  
L. S. Sibley ◽  
...  

AbstractZaireebolavirus (EBOV) is a highly pathogenic filovirus which can result in Ebola virus disease (EVD); a serious medical condition that presents as flu like symptoms but then often leads to more serious or fatal outcomes. The 2013–16 West Africa epidemic saw an unparalleled number of cases. Here we show characterisation and identification of T cell epitopes in surviving patients from Guinea to the EBOV glycoprotein. We perform interferon gamma (IFNγ) ELISpot using a glycoprotein peptide library to identify T cell epitopes and determine the CD4+ or CD8+ T cell component response. Additionally, we generate data on the T cell phenotype and measure polyfunctional cytokine secretion by these antigen specific cells. We show candidate peptides able to elicit a T cell response in EBOV survivors and provide inferred human leukocyte antigen (HLA) allele restriction. This data informs on the long-term T cell response to Ebola virus disease and highlights potentially important immunodominant peptides.


2016 ◽  
Vol 339 (11-12) ◽  
pp. 517-528 ◽  
Author(s):  
Alexandre Hassanin ◽  
Nicolas Nesi ◽  
Julie Marin ◽  
Blaise Kadjo ◽  
Xavier Pourrut ◽  
...  

Author(s):  
Nadege Goumkwa Mafopa ◽  
Gianluca Russo ◽  
Raoul Emeric Guetiya Wadoum ◽  
Emmanuel Iwerima ◽  
Vincent Batwala ◽  
...  

A serosurvey of anti-Ebola Zaire virus nucleoprotein IgG prevalence was carried out among Ebola virus disease survivors and their Community Contacts in Bombali District, Sierra Leone. Our data suggest that the specie of Ebola virus (Zaire) responsible of the 2013-2016 epidemic in West Africa may cause mild or asymptomatic infection in a proportion of cases, possibly due to an efficient immune response.


2014 ◽  
Vol 45 (1) ◽  
pp. 2-5 ◽  
Author(s):  
Colin Brown ◽  
Paul Arkell ◽  
Sakib Rokadiya

Sign in / Sign up

Export Citation Format

Share Document